Shengzhe Shang

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer”.

Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer

Scientific Reports(2020)10.1038/s41598-020-69338-8

N/A

0DataRank · unranked

41 citations

Shengzhe Shang, Zheng Fu, Lilia Gheghiani

MBD2a–NuRD binds to the methylated γ-globin gene promoter and uniquely forms a complex required for silencing of HbF expression

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2302254120

N/A

0DataRank · unranked

49 citations

Xia Li, Alexander Azzo, Tin Truong, Mikhail G. Dozmorov, Charles E. Lyons +4 more

Analysis of the complex between MBD2 and the histone deacetylase core of NuRD reveals key interactions critical for gene silencing

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2307287120

N/A

0DataRank · unranked

15 citations

Shengzhe Shang, Sean Hageman, Gordon D. Ginder, David C. Williams, Gage O. Leighton

Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02125-x

N/A

0DataRank · unranked

7 citations

Lin Li, Jewel Nkwocha, Maciej Kmieciak, Shengzhe Shang, L. Ashley Cowart +13 more